Dynamic contrast-enhanced ultrasonographic (DCE-US) assessment of the early response after combined gemcitabine and HIFU with low-power treatment for the mouse xenograft model of human pancreatic cancer.

MLA

Kim, Jung Hoon, et al. “Dynamic Contrast-Enhanced Ultrasonographic (DCE-US) Assessment of the Early Response after Combined Gemcitabine and HIFU with Low-Power Treatment for the Mouse Xenograft Model of Human Pancreatic Cancer.” European Radiology, vol. 24, no. 9, Sept. 2014, pp. 2059–68. EBSCOhost, https://doi.org/10.1007/s00330-014-3260-4.

APA

Kim, J. H., Kim, H., Kim, Y. J., Lee, J. Y., Han, J. K., & Choi, B.-I. (2014). Dynamic contrast-enhanced ultrasonographic (DCE-US) assessment of the early response after combined gemcitabine and HIFU with low-power treatment for the mouse xenograft model of human pancreatic cancer. European Radiology, 24(9), 2059–2068. https://doi.org/10.1007/s00330-014-3260-4

Chicago

Kim, Jung Hoon, Haeri Kim, Young Jae Kim, Jae Young Lee, Joon Koo Han, and Byung-Ihn Choi. 2014. “Dynamic Contrast-Enhanced Ultrasonographic (DCE-US) Assessment of the Early Response after Combined Gemcitabine and HIFU with Low-Power Treatment for the Mouse Xenograft Model of Human Pancreatic Cancer.” European Radiology 24 (9): 2059–68. doi:10.1007/s00330-014-3260-4.